HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NCCAM Prepares For Intramural Program, More Selective Research Funding

This article was originally published in The Tan Sheet

Executive Summary

NIH's National Center for Complementary & Alternative Medicine will establish its Office of Intramural Research shortly after naming a director to head the new program, an action anticipated by January.

You may also be interested in...



NCCAM Slowing Research Pace, Turning To Program Announcements

The National Center for Complementary & Alternative Medicine will issue proportionately more program announcements (PAs) in the coming year than requests for applications (RFAs), hedging against a possible upsurge of out-year costs for funded grants.

Rx-To-OTC Switch Candidate Negative Lists "Stifle Innovation" - CHPA

FDA should consider all Rx-to-OTC switch candidates on a case-by-case basis and avoid creating "presumptive negative lists" of drug classes not suited to OTC use, the Consumer Healthcare Products Association stresses in Aug. 25 comments to the agency.

NCCAM Intramural Research Program Outlined In Strategic Plan

A continued commitment to sponsoring clinical research on complementary and alternative medicine and the creation of an intramural program at NIH are two central goals highlighted in the National Center for Complementary & Alternative Medicine's draft five-year strategic plan released May 10.

Related Content

Topics

UsernamePublicRestriction

Register

RS132986

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel